D.A. Davidson & Co. Leap Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$0.29 - $0.72 $3,190 - $7,920	11,000 New	11,000 $3,000
Q2 2022 Jul 28, 2022	SELL	$0.96 - $1.91 $2,400 - $4,775	-2,500 Reduced 18.52%	11,000 $13,000
Q1 2021 May 07, 2021	BUY	$1.82 - $3.01 $24,570 - $40,635	13,500 New	13,500 $26,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.